Patient factors | Metastasectomy | No metastasectomy | Hazard ratio |
---|
N = 263 | N = 128 |
---|
ECOG zeroa | 68% | 36% | Â |
Median %FEV1b | 96% | 87% | Â |
Solitary metastasisc | 65% | 31% | 2.04 |
CEA < 5 ng/mld | 31% | 21% | 1.91 |
No liver metastases | 36% | 28% | 1.22 |
Five-year survival | 47% | 22% | Â |
- aEaster Cooperative Oncology Group 0–5 where zero is unimpaired
- bForced Expiratory Volume in 1st second as a percentage of predicted values based on height and sex
- cThe hazard ratio is for multiple versus solitary. Here are given the % of patients with a solitary metastasis in each group
- dThe tumour marker carcinoembryonic antigen. All hazard ratios are from the meta-analysis of Gonzalez et al. [4]